FDA vows to overhaul drug safety system (Los Angeles Times)
The Food and Drug Administration pledged Tuesday to undertake a major overhaul of its drug safety system, just months after a blue ribbon panel of medical and legal experts concluded that the agency’s priorities were skewed toward approving new medications without enough follow-up of risky side effects.